Contact
Please use this form to send email to PR contact of this press release:
Noveome Biotherapeutics, Inc. Completes First Close of $40 Million Series E Financing to Support Clinical Trials in NEC
TO:
Gretchen Kraemer
Noveome Biotherapeutics, Inc.
+1 412-402-9914